DK0419446T3 - Kompleks, som er egnet til gennemførelse af en fremgangsmåde til rensning af præ-S-hepatitis-B-virus-overfladeantigen - Google Patents

Kompleks, som er egnet til gennemførelse af en fremgangsmåde til rensning af præ-S-hepatitis-B-virus-overfladeantigen

Info

Publication number
DK0419446T3
DK0419446T3 DK90890262.0T DK90890262T DK0419446T3 DK 0419446 T3 DK0419446 T3 DK 0419446T3 DK 90890262 T DK90890262 T DK 90890262T DK 0419446 T3 DK0419446 T3 DK 0419446T3
Authority
DK
Denmark
Prior art keywords
hepatitis
surface antigen
virus surface
carrying
complex suitable
Prior art date
Application number
DK90890262.0T
Other languages
Danish (da)
English (en)
Inventor
Johann Dr Eibl
Friedrich Prof Dr Dorner
Arthur Dr Mitterer
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of DK0419446T3 publication Critical patent/DK0419446T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90890262.0T 1989-09-20 1990-09-13 Kompleks, som er egnet til gennemførelse af en fremgangsmåde til rensning af præ-S-hepatitis-B-virus-overfladeantigen DK0419446T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT2198/89A AT392417B (de) 1989-09-20 1989-09-20 Komplex geeignet zur durchfuehrung eines verfahrens zur reinigung von pre-s-hepatitis-b- virus-oberflaechenantigen

Publications (1)

Publication Number Publication Date
DK0419446T3 true DK0419446T3 (da) 1995-08-28

Family

ID=3529817

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90890262.0T DK0419446T3 (da) 1989-09-20 1990-09-13 Kompleks, som er egnet til gennemførelse af en fremgangsmåde til rensning af præ-S-hepatitis-B-virus-overfladeantigen

Country Status (9)

Country Link
EP (1) EP0419446B1 (ja)
JP (1) JP2721033B2 (ja)
AT (2) AT392417B (ja)
CA (1) CA2025263A1 (ja)
DE (1) DE59008927D1 (ja)
DK (1) DK0419446T3 (ja)
ES (1) ES2074558T3 (ja)
FI (1) FI101625B (ja)
NO (1) NO300421B1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111659355B (zh) * 2020-06-23 2022-12-13 武汉瑞法医疗器械有限公司 烷基化修饰的乙肝病毒免疫吸附剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45247A0 (en) * 1974-07-11 1974-10-22 Yeda Res & Dev Water insoluble protein preparations
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen
ATE73349T1 (de) * 1984-06-18 1992-03-15 Chiron Corp Hepatitisoberflaechenantigenpartikelvakzin.
JPS6137738A (ja) * 1984-07-31 1986-02-22 Tetsuo Nakamura B型肝炎ワクチン
EP0243103B1 (en) * 1986-04-25 1992-12-30 Merck & Co. Inc. Purification of pre-s hbsag by polymerized serum albumin affinity binding
US4855055A (en) * 1988-09-28 1989-08-08 National Science Council Isolation and purification pre-S2 containing hepatitis B virus surface antigen by chemical affinity chromatography

Also Published As

Publication number Publication date
CA2025263A1 (en) 1991-03-21
ES2074558T3 (es) 1995-09-16
DE59008927D1 (de) 1995-05-24
NO904085D0 (no) 1990-09-19
FI904412A0 (fi) 1990-09-07
FI101625B1 (fi) 1998-07-31
FI101625B (fi) 1998-07-31
JP2721033B2 (ja) 1998-03-04
EP0419446B1 (de) 1995-04-19
ATA219889A (de) 1990-09-15
JPH03120300A (ja) 1991-05-22
NO904085L (no) 1991-03-21
NO300421B1 (no) 1997-05-26
ATE121417T1 (de) 1995-05-15
AT392417B (de) 1991-03-25
EP0419446A1 (de) 1991-03-27

Similar Documents

Publication Publication Date Title
LU90911I2 (fr) Antig-ne recombinant comprenant les s-quences pre-S1 et S du virus de l'h-patite B ingr-dient actif de hepacare
DE3679708D1 (de) Verfahren zur verleihung von immuntoleranz gegen ein spezifisches antigen.
DE69534872D1 (de) Gereinigte primate clta-8 antigene und verwandte reagenzien
RU93058563A (ru) Полипептиды, иммунореагент, способ определения антител, способ индукции иммунного ответа, композиции, способ получения полипептида
ATE70455T1 (de) Verfahren zur reinigung von serumalbumin.
ITMI931522A1 (it) Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv)
FI893702A (fi) Foerfarande foer mikrobiologisk framstaellning av humant serumalbumin och andra heterologa proteiner ur jaest.
DE69331507D1 (de) Verfahren zur Reinigung von menschlichem, rekombinantem Serumalbumin
EP0261224A4 (en) SYNTHETIC HTLV III PEPTIDE COMPOSITIONS AND THEIR USE.
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
DK235289A (da) Ekspression af hapatitis b s- og praes2-proteiner i methylotrophe gaerarter
DK0791064T3 (da) Fremgangsmåde til forögelse af immunogeniciteten af en immunogen forbindelse eller et hapten og anvendelse heraf til fremstilling af vacciner
EP0687182A4 (en) PEPTIDES FOR INDUCING A RESPONSE OF THE CYTOTOXIC T-LYMPHOCYTES AGAINST THE HEPATITIS B VIRUS
DK57284A (da) Fremgangsmaade til inaktivering af et lipidvirus
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
DK0419446T3 (da) Kompleks, som er egnet til gennemførelse af en fremgangsmåde til rensning af præ-S-hepatitis-B-virus-overfladeantigen
BR9603826A (pt) Processo para recuperar imunoglobulina de frações produzidas durante o fracionamento de plasma sanguíneo humano
ATE179428T1 (de) Verfahren zur herstellung von hepatitis antigenen und impfstoffen
KR920002629A (ko) B형 간염 코어 항원의 아미노산 잔기 서열
FR2689398B1 (fr) Compositions destinées au traitement de l'infection et des maladies provoquées par le virus de l'hépatite B (HBV).
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
EP0243103A3 (en) Purification of pre-s hbsag by polymerized serum albumin affinity binding
ATE76082T1 (de) Reinigungsmethode fuer antikoerper.
EP0175269A3 (en) Immunogen conjugates and the use thereof in a dihydropyridine assay
DE69121933D1 (de) Nukleinsäuren, Antigene und Antikörper betreffend Non-A, Non-B Hepatitis und deren Nachweisreagenzien